HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imaging of Ménière's disease after intravenous administration of single-dose gadodiamide: utility of multiplication of MR cisternography and HYDROPS image.

Abstract
A HYDROPS (HYbriD of Reversed image Of Positive endolymph signal and native image of positive perilymph Signal) image, created by subtracting a positive endolymph image from a positive perilymph image after intravenous injection of single-dose gadodiamide, has been reported to facilitate recognition of endolymphatic hydrops. To further increase the contrast-to-noise ratio (CNR) of HYDROPS images, we multiplied a T2-weighted MR cisternographic image onto the HYDROPS image. Ten patients with suspected Ménière's disease were included. The average CNR of generated images increased to more than 200 times that of HYDROP images.
AuthorsShinji Naganawa, Masahiro Yamazaki, Hisashi Kawai, Kiminori Bokura, Michihiko Sone, Tsutomu Nakashima
JournalMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine (Magn Reson Med Sci) Vol. 12 Issue 1 Pg. 63-8 (Mar 25 2013) ISSN: 1880-2206 [Electronic] Japan
PMID23474961 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • gadodiamide
  • Gadolinium DTPA
Topics
  • Adolescent
  • Adult
  • Aged
  • Algorithms
  • Contrast Media (administration & dosage)
  • Female
  • Gadolinium DTPA (administration & dosage)
  • Humans
  • Image Enhancement (methods)
  • Imaging, Three-Dimensional (methods)
  • Injections, Intravenous
  • Magnetic Resonance Imaging (methods)
  • Male
  • Meniere Disease (pathology)
  • Middle Aged
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: